Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
Bilastine is a second generation antihistamine indicated for the treatment of seasonal or perennial allergic rhinoconjunctivitis and chronic urticaria with a daily dose of 20 mg, in adults and children over 12 years of age. The efficacy of bilastine has been shown to be similar to that of the compar...
| Main Authors: | , , , |
|---|---|
| Format: | info:eu-repo/semantics/article |
| Language: | eng |
| Published: |
Dove Medical Press
2014
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10171/36423 |